CorMedix (CRMD) EBT Margin Growth (3y) (2016 - 2025)
CorMedix (CRMD) EBT Margin Growth (3y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
CorMedix |
631,378.03 |
-154.57 Mn |
107.31 Mn |
2.77 Mn |
| Date | Value |
| Dec 31, 2025 |
2.77 Mn |
| Sep 30, 2025 |
10.06 Mn |
| Jun 30, 2025 |
3.86 Mn |
| Mar 31, 2025 |
9.20 Mn |
| Dec 31, 2024 |
1.39 Mn |
| Sep 30, 2024 |
2.25 Mn |
| Jun 30, 2024 |
7.01 Mn |
| Dec 31, 2022 |
-623,087.00 |
| Sep 30, 2022 |
-9.17 Mn |
| Jun 30, 2022 |
-2.22 Mn |
| Mar 31, 2022 |
-8.88 Mn |
| Dec 31, 2021 |
-2.19 Mn |
| Sep 30, 2021 |
-1.98 Mn |
| Jun 30, 2021 |
4.15 Mn |
| Mar 31, 2021 |
3.57 Mn |
| Dec 31, 2020 |
15,456.00 |
| Sep 30, 2020 |
596,596.00 |
| Jun 30, 2020 |
-4.93 Mn |
| Mar 31, 2020 |
1.17 Mn |
| Dec 31, 2019 |
-4.30 Mn |